BCR and B-cell chronic lymphocytic leukemia: Having identified several genes involved in (proximal) BCR signaling and BCR-controlled integrin-mediated adhesion, our results provide targets for therapeutic intervention of CLL, MCL, and WM, which rely on BCR-controlled adhesion of the malignant cells for their retention and survival in lymphoid tissues.